Xrf Scientific has reported that its fiscal year sales revenue experienced a surge, with an increase of 38% bringing it to A$55.2 million.

The company also declared a final fully franked dividend of 3.3 AU cents per share.

As it looks towards fiscal year 2024, among its key focus areas is the intensification of its sales strategy on XRTGA.

Company description: Xrf Scientific (ASX:XRF) is a main market player in the manufacture of precision tools and equipment for scientific testing and analysis.